Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. Its product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Kennewick, WA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
1
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Vivos Inc market cap is $19.79M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vivos Inc 52 week high is $0.1244 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vivos Inc 52 week low is $0.034 as of November 22, 2026.
Vivos Inc stock price today is $0.04.
Vivos Inc stock price yesterday was $0.0411.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Vivos Inc's P/E ratio is -4.94.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Vivos Inc P/B ratio is -2.7155.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Vivos Inc 50-day moving average is $0.0455.